IP Library Granted Patent US 6,988,619
Granted Patent B2
US 6,988,619 · App. 10/297,257 · Granted Jan 24, 2006

Medicinal product package for eradication therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,988,619
App. No.
10/297,257
Granted
Jan 24, 2006
Kind
B2
Abstract

The object of the present invention is to provide a medicinal product package which is suitable for microbe eradication therapy and with which the patient's compliance is increased and thus the result of therapy is improved.

Claims (13)

1. A medicinal product package for improving compliance in microbe eradication therapy, where the package has: (a) a multiplicity of blister cards of generally uniform planar dimensions, where the blister cards are disposed in a stack with their principal dimensions oriented generally horizontally and arranged in order of card use, with the first card to be used lying right at the bottom; (b) a container which houses the stack of blister cards, where the container has an access for removing the blister card lying right at the bottom, and where the container has means for indicating the remaining days of treatment as a function of the blister cards removed; and (c) a leaflet with patient information located in the container under the stack of blister cards.

2. A medicinal product package as claimed in claim 1 , where the access for removing the blister card lying right at the bottom is a first zone of the container which comprises a perforated line and can be detached from the remainder of the container.

3. A medicinal product package as claimed in claim 1 , where the means for indicating the remaining days of treatment as a function of the blister cards removed is a vertically oriented elongate, transparent zone in a side wall of the container, and a scale with the number of days of treatment as a function of the height of the stack of blister cards is printed horizontally on the transparent zone or on the container adjacent to the elongate transparent zone.

4. A medicinal product package as claimed in claim 1 , where at least one of the blister cards contains a daily dose of medicaments, and the medicaments are disposed in sections on at least one of the blister cards according to the time of day at which they must be taken.

5. A method of using the medicinal product packaging as claimed in claim 1 for controlling Helicobacter pylori comprising providing a therapeutically effective amount of pantoprazole and at least one antibiotic to a patient in need thereof, wherein the pantoprazole and the at least one antibiotic are provided in the medicinal product packaging as claimed in claim 1 .

6. The method as claimed in claim 5 , wherein the at least one antibiotic is selected from the group consisting of amoxicillin, clarithromycin, metronidazole, tinidazole, azithromycin, tetracycline and mixtures thereof.

7. A medicinal product package as claimed in claim 1 , wherein the blister card contains at least one proton pump inhibitor in combination with at least one antibiotic.

8. A medicinal product package as claimed in claim 7 , wherein said at least one proton pump inhibitor is selected from the group consisting of pantoprazole, omeprazole, and mixtures thereof.

9. A medicinal product package as claimed in claim 7 , wherein said at least one antibiotic is selected from the group consisting of amoxicillin, clarithromycin, azithromycin, tetracycline, metronidazole, tinidazole, and mixtures thereof.

10. A medicinal product package as claimed in claim 7 , wherein the blister card contains at least two antibiotics.

11. A medicinal product package as claimed in claim 1 , wherein said leaflet must be removed from the container before said blister card lying right at the bottom can be removed.

12. A medicinal product package as claimed in claim 1 , wherein four to twenty blister cards are present in said package.

13. A medicinal product package as claimed in claim 12 , wherein seven to fourteen blister cards are present in said package.

Assignments (6)
CHANGE OF NAME Recorded Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
MERGER Recorded Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
MERGER Recorded Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
CHANGE OF NAME Recorded Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
CHANGE OF NAME Recorded Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019781/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2002
From: KLATT, ANDREAS
To: ALTANA PHARMA AG
Reel/Frame 013902/0107 →